Brokerages expect Tivity Health Inc (NASDAQ:TVTY) to report $301.34 million in sales for the current fiscal quarter, Zacks reports. Six analysts have made estimates for Tivity Health’s earnings, with estimates ranging from $286.01 million to $308.20 million. Tivity Health posted sales of $151.47 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 98.9%. The business is expected to announce its next earnings results on Monday, November 4th.

According to Zacks, analysts expect that Tivity Health will report full year sales of $1.13 billion for the current fiscal year, with estimates ranging from $1.13 billion to $1.14 billion. For the next year, analysts forecast that the firm will report sales of $1.32 billion, with estimates ranging from $1.30 billion to $1.34 billion. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for Tivity Health.

Tivity Health (NASDAQ:TVTY) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.64 EPS for the quarter, missing the Zacks’ consensus estimate of $0.66 by ($0.02). The firm had revenue of $340.40 million during the quarter, compared to analyst estimates of $340.73 million. Tivity Health had a net margin of 8.88% and a return on equity of 24.83%. Tivity Health’s quarterly revenue was up 124.1% on a year-over-year basis. During the same quarter last year, the firm earned $0.53 earnings per share.

A number of equities analysts have weighed in on the stock. Chardan Capital dropped their target price on shares of Tivity Health from $33.00 to $24.00 and set a “buy” rating for the company in a research note on Friday, August 23rd. Barrington Research reaffirmed an “outperform” rating on shares of Tivity Health in a research note on Thursday, August 8th. Piper Jaffray Companies dropped their target price on shares of Tivity Health from $33.00 to $25.00 and set an “overweight” rating for the company in a research note on Thursday, August 8th. Cantor Fitzgerald set a $45.00 target price on shares of Tivity Health and gave the stock a “buy” rating in a research note on Monday, August 26th. Finally, BidaskClub downgraded shares of Tivity Health from a “buy” rating to a “hold” rating in a research note on Wednesday, September 4th. Two equities research analysts have rated the stock with a sell rating, one has assigned a hold rating and eight have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $31.33.

A number of institutional investors and hedge funds have recently made changes to their positions in TVTY. Shell Asset Management Co. bought a new position in shares of Tivity Health in the first quarter valued at about $33,000. Public Employees Retirement System of Ohio increased its position in Tivity Health by 47.4% during the second quarter. Public Employees Retirement System of Ohio now owns 2,409 shares of the company’s stock worth $40,000 after acquiring an additional 775 shares during the period. Wealthcare Advisory Partners LLC bought a new position in Tivity Health during the first quarter worth about $49,000. Resources Investment Advisors LLC. bought a new position in Tivity Health during the second quarter worth about $61,000. Finally, Meadow Creek Investment Management LLC increased its position in Tivity Health by 22.8% during the second quarter. Meadow Creek Investment Management LLC now owns 4,912 shares of the company’s stock worth $81,000 after acquiring an additional 912 shares during the period.

NASDAQ:TVTY traded down $0.55 on Thursday, reaching $17.22. The stock had a trading volume of 497,932 shares, compared to its average volume of 498,623. The company has a market capitalization of $849.99 million, a P/E ratio of 7.36, a price-to-earnings-growth ratio of 0.78 and a beta of 1.05. Tivity Health has a 1-year low of $14.84 and a 1-year high of $41.46. The company has a quick ratio of 0.76, a current ratio of 0.94 and a debt-to-equity ratio of 2.06. The stock has a fifty day moving average price of $17.83 and a 200-day moving average price of $18.28.

Tivity Health Company Profile

Tivity Health, Inc provides fitness and health improvement programs in the United States. The company offers SilverSneakers senior fitness program to the members of Medicare advantage, Medicare supplement; and Prime fitness, a fitness facility access program through commercial health plans and employers.

See Also: Market Capitalization – What it Means for Investors

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.